Recommended Dose for Liver SBRT
For adults with adequate liver function (Child-Pugh A or B) and lesions ≤5 cm, the recommended SBRT dose is 30-50 Gy delivered in 3-5 fractions, with the specific dose determined by tumor size, liver function, and ability to meet normal organ constraints. 1
Dose Selection Algorithm
For Child-Pugh A Patients:
- Lesions <3 cm: 45-60 Gy in 3 fractions (most common: 60 Gy/3 fractions) 2, 3
- Lesions 3-5 cm: 40-50 Gy in 5 fractions 4, 5
- Alternative hypofractionated approach: 50 Gy in 5 fractions or 50-55 Gy in 10 fractions 4, 6
For Child-Pugh B Patients:
Dose modifications and strict adherence to dose constraints are mandatory 1. The evidence specifically notes that Child-Pugh B patients require more conservative dosing:
- Lesions <3 cm with CP-B7: 40-45 Gy in 5 fractions 5
- CP-B8-9: Further dose reduction to 30-40 Gy in 5-6 fractions 7
- CP-C: Extremely limited data; doses as low as 26 Gy BED10 may be appropriate 8
Critical Dosimetric Constraints
The 2022 Korean guidelines 9 specify that EBRT should only be performed when the volume receiving ≤30 Gy comprises ≥40% of total liver volume. This constraint is essential for preventing radiation-induced liver disease (RILD).
Evidence Quality and Nuances
The NCCN 2021 guidelines 1 emphasize that most safety and efficacy data exist for Child-Pugh A patients, with limited safety data for Child-Pugh B. The guidelines explicitly state that SBRT dosing of 30-50 Gy in 3-5 fractions depends on "ability to meet normal organ constraints and underlying liver function."
Research data 3 comparing 45 Gy versus 60 Gy in 3 fractions for lesions ≤3 cm showed no significant difference in local control (both >95% at 3 years) or toxicity, suggesting that lower doses may be equally effective for smaller lesions while potentially safer for patients with compromised liver function.
Common Pitfalls to Avoid
Heat-sink effect consideration: SBRT is particularly valuable for lesions >3 cm or those adjacent to large vessels where thermal ablation has higher failure rates 1
Location matters: Lesions in contact with large vessels or in challenging locations may benefit from SBRT over ablation, as SBRT is not susceptible to heat-sink effects 10
No strict size limit: While most data support lesions ≤5 cm, SBRT can be used for larger lesions if sufficient uninvolved liver exists and dose constraints can be met 1
Child-Pugh C: Safety has not been established; these patients should generally not receive SBRT 1
Treatment Delivery Considerations
Hypofractionated schedules may be considered as alternatives 1, particularly for patients with borderline liver function or larger tumors where meeting dose constraints with 3-5 fractions proves challenging. The Korean practice patterns 2 show that 60 Gy in 3 fractions is the most commonly used regimen, though this reflects practice in predominantly Child-Pugh A patients.
For patients with decompensated liver function (Child-Pugh B8-9), recent data 7, 11 suggest SBRT can be delivered safely with doses of 30-40 Gy in 5-6 fractions, achieving 96% 1-year local control with acceptable toxicity when careful patient selection and treatment planning are employed.